DR. DREAM
DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 40 patients (estimated)
- Sponsors
- Fred Hutchinson Cancer Research Center
- Collaborators
- Simcha Therapeutics
- Tags
- Interleukin 18 (IL-18)
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1967
- NCT Identifier
- NCT06492707
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.